- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03621228
MindfulGarden in Treatment of Hyperactive Delirium in a Hospital Setting
A Pilot Study of an Interactive Digital Technology (MindfulGarden) in Treatment of Hyperactive Delirium in a Hospital Setting
Study Overview
Detailed Description
The primary objective of the study is to establish whether the key components necessary for conducting a full randomized control study in the future, such as recruitment, consent, randomization, and treatment processes are working well and all function together. As a secondary objective, the investigators will determine trends in patients exposed to MindfulGarden (MG), for example:
- At the first and second administration of the Confusion Assessment Method - short form (CAM) after admission to a medical ward are there more, the same or fewer patients in the intervention group than in the control group whose CAM scores change from positive to negative?
- During the first 24 hours after admission to a medical ward, did fewer, the same, or a greater number of patients in the intervention than in the control group experience significant events/alerts (e.g. aggressive/violent behaviours, falls, code white)?
- During the first 24 hours after admission to a medical ward, were fewer, the same, or a greater number of patients in the intervention than in the control group administered psychotropic drugs (e.g. haloperidol, risperidone, quetiapine, lorazepam)? were more, the same, or fewer administered sleeping aids (e.g. trazodone, melatonin)?
- During the first 24 hours after admission to a medical ward, were fewer, the same, or a greater number of patients in the intervention than in the control group physically restrained?
- Was mean length of stay from time of admission to a medical ward until discharge due to death, return to place of residence before admission or to a different place of residence longer, the same or shorter in the intervention than in the control group?
- Were there more, the same or fewer deaths or discharges to a higher level of care (e.g. to assisted living, to a complex care facility in patients who previously lived at home) in the intervention than the control group?
Additionally, to the extent that movement and vocalization are reflective of anxiety, agitation and/or aggression (i.e. responsive behaviours) the investigators also want to determine whether there is a correlation between changes in these as recorded by the MG and any of the indicators listed in 1-6 above.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All patients aged 65 years or older admitted to the Emergency Department who have a diagnosis of hyperactive delirium as defined by the short CAM
Exclusion Criteria:
- Patients with severe vision impairment or who are legally blind
- Patients for whom a bed in a medical ward was not available within 12 hours of a diagnosis of hyperactive delirium (i.e. who remained in the Emergency Department more than 12 hours)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: MindfulGarden
Standard care + exposure to an interactive digital device
|
MindfulGarden (MG) is an interactive digital technology that combines use of a smart television with sensors to intelligently generate content based on patient voice and gesture input, triggering a multi-layered visual 'garden' on-screen to arrest and de-escalate anxiety and aggression in treatment of hospitalized elderly diagnosed with hyperactive delirium.
|
No Intervention: Control
Standard care only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recruitment Rates
Time Frame: Number enrolled within 12 hours of admission to Emergency Department
|
Number of participants approached and their rate of consent
|
Number enrolled within 12 hours of admission to Emergency Department
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Estimate the potential effect size
Time Frame: 24-hour period following transfer from Emergency Department
|
MG association with reducing delirium duration as measured CAM - short
|
24-hour period following transfer from Emergency Department
|
Adverse Outcomes (number of patients with aggressive/violent behaviours, falls, code white)
Time Frame: 24-hour period following transfer from Emergency Department
|
Assess from patients medical chart
|
24-hour period following transfer from Emergency Department
|
Psychotropic Drug Consumption
Time Frame: 24-hour period following transfer from Emergency Department
|
Assess from patient's medical chart
|
24-hour period following transfer from Emergency Department
|
Application of Physical Restraints
Time Frame: 24-hour period following transfer from Emergency Department
|
Assess from patient's medical chart
|
24-hour period following transfer from Emergency Department
|
Length of Stay
Time Frame: Date of study enrolment through to discharge from hospital, or date of study enrolment up to 30 days
|
Assess from patient's medical chart
|
Date of study enrolment through to discharge from hospital, or date of study enrolment up to 30 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gloria Gutman, Simon Fraser University
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MindfulGarden-H-Pilot
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperactive Delirium
-
Stanford UniversityCompletedHypoactive Delirium | Hyperactive Delirium | Mixed Type DeliriumUnited States
-
Stanford UniversityTerminatedHyperactive Delirium | Mixed DeliriumUnited States
-
Alexandria UniversitySuez Canal University; Gezira UniversityCompleted
-
Universidad de SantanderUnknownDelirium of Mixed Origin | Hypoactive Delirium | Hyperactive DeliriumColombia
-
Bruyere Research InstituteThe Ottawa Hospital; Foothills Medical Centre; Bruyère Continuing CareRecruitingDelirium of Mixed Origin | Hyperactive DeliriumCanada
-
Tan Tock Seng HospitalRecruitingAdvanced Cancer | Hyperactive Delirium | Olanzapine | Haloperidol | End-stage Organ DiseaseSingapore
-
M.D. Anderson Cancer CenterCompleted
-
University of MiamiWithdrawnPneumonia, Viral | Covid19 | Hyperactive DeliriumUnited States
-
Sync-Think, Inc.Sutter HealthUnknownADHD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - ImpulsiveUnited States
-
Fundacion para la Formacion e Investigacion Sanitarias...Unknown